Cited by 123Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsCancer-related Molecular Pathways

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Evolving views of telomerase and cancer

Blasco, M·2003·Trends in Cell Biology

Abstract

The maintenance of telomeres, nucleoprotein structures that constitute the ends of eukaryotic chromosomes, regulates many crucial cellular functions and might, in multicellular organisms, participate in the control of complex phenotypes such as aging and cancer. Stabilization of telomere length is strongly associated with cellular immortalization, and constitutive telomerase activation occurs in most human cancers. Such observations form the basis for the prevailing model that postulates that alterations in telomere biology both suppress and facilitate malignant transformation by regulating genomic stability and cell life span. However, recent findings suggest that telomere maintenance might not be an obligate requirement for initial tumor formation in some settings and that telomerase activation contributes to tumorigenesis independently of its role in maintaining telomere length. These recent developments indicate that our understanding of telomere biology remains incomplete and implicate additional complexity in the relationships among telomeres, telomerase and cancer.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0962-8924(03)00085-0

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TERT promotes tumor development even in settings of ample telomere reserve.

    “Moreover, recent findings indicate that TERT promotes tumor development even in settings of ample telomere reserve, although the mechanisms underlying these telomere length-independent activities of TERT remain unclear9–13.”

Citations

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Blasco, M.
Affiliations
Consejo Superior de Investigaciones Científicas (ES)
Corresponding author
Blasco, M
Venue
Trends in Cell Biology
Publisher
Elsevier BV
Published
2003-06
Volume
13
Issue
6
Pages
289-294
ISSN
0962-8924 (ISSN-L)
OpenAlex
W2026654107
Cited by
123
References
60
Citations by year
2024: 1 · 2022: 3 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 8
FWCI
7.86
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (K01CA94223, K01CA094223)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
telomerase, telomere maintenance, telomeres, cancer, malignant transformation, genome stability, cell immortalization, aging, carcinogenesis, cell lifespan
MeSH terms
Animals, Enzyme Activation, Humans, Neoplasms, Telomerase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review